United Therapeutics CorporationUTHRNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank50
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P50
Within normal range
vs 2Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 14.35% |
| 2024 | 17.89% |
| 2023 | 26.35% |
| 2022 | -40.21% |
| 2021 | 50.99% |
| 2020 | -69.75% |
| 2019 | 230.43% |
| 2018 | 35.26% |
| 2017 | 79.27% |
| 2016 | -39.78% |